Cerebrovascular Disease Market - Global Outlook and Forecast 2022-2028

March 2022 | 69 pages | ID: CE1438EA3B57EN
Market Monitor Global

Abstracts

Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is any kind of restriction in the blood flow, the brain cells begin to die. The prime causes of cerebrovascular disease are cerebral thrombosis, cerebral embolism, and cerebral hemorrhage. Due to cerebrovascular disease, part of the brain is affected due to bleeding and thereby leads to different types of cerebrovascular diseases such as stroke, transient ischaemic attack (TIA), vascular dementia, and subarachnoid hemorrhage.

This report contains market size and forecasts of Cerebrovascular Disease in Global, including the following market information:

Global Cerebrovascular Disease Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cerebrovascular Disease market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Carotid Endarterectomy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cerebrovascular Disease include Johnson & Johnson, Amgen, GlaxoSmithKline, Sanofi-Aventis, Merck, Sangamo BioSciences and Aldagen, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cerebrovascular Disease companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cerebrovascular Disease Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cerebrovascular Disease Market Segment Percentages, by Type, 2021 (%)

• Carotid Endarterectomy
• Carotid Angioplasty Or Carotid Artery Stenting
• Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)

Global Cerebrovascular Disease Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cerebrovascular Disease Market Segment Percentages, by Application, 2021 (%)

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Centers
• Contract Research Organizations
• Others

Global Cerebrovascular Disease Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cerebrovascular Disease Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cerebrovascular Disease revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cerebrovascular Disease revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Amgen
• GlaxoSmithKline
• Sanofi-Aventis
• Merck
• Sangamo BioSciences
• Aldagen

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cerebrovascular Disease Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cerebrovascular Disease Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CEREBROVASCULAR DISEASE OVERALL MARKET SIZE

2.1 Global Cerebrovascular Disease Market Size: 2021 VS 2028
2.2 Global Cerebrovascular Disease Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cerebrovascular Disease Players in Global Market
3.2 Top Global Cerebrovascular Disease Companies Ranked by Revenue
3.3 Global Cerebrovascular Disease Revenue by Companies
3.4 Top 3 and Top 5 Cerebrovascular Disease Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cerebrovascular Disease Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cerebrovascular Disease Players in Global Market
  3.6.1 List of Global Tier 1 Cerebrovascular Disease Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cerebrovascular Disease Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cerebrovascular Disease Market Size Markets, 2021 & 2028
  4.1.2 Carotid Endarterectomy
  4.1.3 Carotid Angioplasty Or Carotid Artery Stenting
  4.1.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
4.2 By Type - Global Cerebrovascular Disease Revenue & Forecasts
  4.2.1 By Type - Global Cerebrovascular Disease Revenue, 2017-2022
  4.2.2 By Type - Global Cerebrovascular Disease Revenue, 2023-2028
  4.2.3 By Type - Global Cerebrovascular Disease Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cerebrovascular Disease Market Size, 2021 & 2028
  5.1.2 Academic & Research Institutes
  5.1.3 Pharmaceutical & Biotechnology Companies
  5.1.4 Hospitals & Diagnostic Centers
  5.1.5 Contract Research Organizations
  5.1.6 Others
5.2 By Application - Global Cerebrovascular Disease Revenue & Forecasts
  5.2.1 By Application - Global Cerebrovascular Disease Revenue, 2017-2022
  5.2.2 By Application - Global Cerebrovascular Disease Revenue, 2023-2028
  5.2.3 By Application - Global Cerebrovascular Disease Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cerebrovascular Disease Market Size, 2021 & 2028
6.2 By Region - Global Cerebrovascular Disease Revenue & Forecasts
  6.2.1 By Region - Global Cerebrovascular Disease Revenue, 2017-2022
  6.2.2 By Region - Global Cerebrovascular Disease Revenue, 2023-2028
  6.2.3 By Region - Global Cerebrovascular Disease Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cerebrovascular Disease Revenue, 2017-2028
  6.3.2 US Cerebrovascular Disease Market Size, 2017-2028
  6.3.3 Canada Cerebrovascular Disease Market Size, 2017-2028
  6.3.4 Mexico Cerebrovascular Disease Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cerebrovascular Disease Revenue, 2017-2028
  6.4.2 Germany Cerebrovascular Disease Market Size, 2017-2028
  6.4.3 France Cerebrovascular Disease Market Size, 2017-2028
  6.4.4 U.K. Cerebrovascular Disease Market Size, 2017-2028
  6.4.5 Italy Cerebrovascular Disease Market Size, 2017-2028
  6.4.6 Russia Cerebrovascular Disease Market Size, 2017-2028
  6.4.7 Nordic Countries Cerebrovascular Disease Market Size, 2017-2028
  6.4.8 Benelux Cerebrovascular Disease Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cerebrovascular Disease Revenue, 2017-2028
  6.5.2 China Cerebrovascular Disease Market Size, 2017-2028
  6.5.3 Japan Cerebrovascular Disease Market Size, 2017-2028
  6.5.4 South Korea Cerebrovascular Disease Market Size, 2017-2028
  6.5.5 Southeast Asia Cerebrovascular Disease Market Size, 2017-2028
  6.5.6 India Cerebrovascular Disease Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cerebrovascular Disease Revenue, 2017-2028
  6.6.2 Brazil Cerebrovascular Disease Market Size, 2017-2028
  6.6.3 Argentina Cerebrovascular Disease Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cerebrovascular Disease Revenue, 2017-2028
  6.7.2 Turkey Cerebrovascular Disease Market Size, 2017-2028
  6.7.3 Israel Cerebrovascular Disease Market Size, 2017-2028
  6.7.4 Saudi Arabia Cerebrovascular Disease Market Size, 2017-2028
  6.7.5 UAE Cerebrovascular Disease Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Cerebrovascular Disease Major Product Offerings
  7.1.4 Johnson & Johnson Cerebrovascular Disease Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Cerebrovascular Disease Major Product Offerings
  7.2.4 Amgen Cerebrovascular Disease Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 GlaxoSmithKline
  7.3.1 GlaxoSmithKline Corporate Summary
  7.3.2 GlaxoSmithKline Business Overview
  7.3.3 GlaxoSmithKline Cerebrovascular Disease Major Product Offerings
  7.3.4 GlaxoSmithKline Cerebrovascular Disease Revenue in Global Market (2017-2022)
  7.3.5 GlaxoSmithKline Key News
7.4 Sanofi-Aventis
  7.4.1 Sanofi-Aventis Corporate Summary
  7.4.2 Sanofi-Aventis Business Overview
  7.4.3 Sanofi-Aventis Cerebrovascular Disease Major Product Offerings
  7.4.4 Sanofi-Aventis Cerebrovascular Disease Revenue in Global Market (2017-2022)
  7.4.5 Sanofi-Aventis Key News
7.5 Merck
  7.5.1 Merck Corporate Summary
  7.5.2 Merck Business Overview
  7.5.3 Merck Cerebrovascular Disease Major Product Offerings
  7.5.4 Merck Cerebrovascular Disease Revenue in Global Market (2017-2022)
  7.5.5 Merck Key News
7.6 Sangamo BioSciences
  7.6.1 Sangamo BioSciences Corporate Summary
  7.6.2 Sangamo BioSciences Business Overview
  7.6.3 Sangamo BioSciences Cerebrovascular Disease Major Product Offerings
  7.6.4 Sangamo BioSciences Cerebrovascular Disease Revenue in Global Market (2017-2022)
  7.6.5 Sangamo BioSciences Key News
7.7 Aldagen
  7.7.1 Aldagen Corporate Summary
  7.7.2 Aldagen Business Overview
  7.7.3 Aldagen Cerebrovascular Disease Major Product Offerings
  7.7.4 Aldagen Cerebrovascular Disease Revenue in Global Market (2017-2022)
  7.7.5 Aldagen Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cerebrovascular Disease Market Opportunities & Trends in Global Market
Table 2. Cerebrovascular Disease Market Drivers in Global Market
Table 3. Cerebrovascular Disease Market Restraints in Global Market
Table 4. Key Players of Cerebrovascular Disease in Global Market
Table 5. Top Cerebrovascular Disease Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cerebrovascular Disease Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cerebrovascular Disease Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cerebrovascular Disease Product Type
Table 9. List of Global Tier 1 Cerebrovascular Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cerebrovascular Disease Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cerebrovascular Disease Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cerebrovascular Disease Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cerebrovascular Disease Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cerebrovascular Disease Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cerebrovascular Disease Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cerebrovascular Disease Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cerebrovascular Disease Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cerebrovascular Disease Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cerebrovascular Disease Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cerebrovascular Disease Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cerebrovascular Disease Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cerebrovascular Disease Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cerebrovascular Disease Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cerebrovascular Disease Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cerebrovascular Disease Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cerebrovascular Disease Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cerebrovascular Disease Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cerebrovascular Disease Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cerebrovascular Disease Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Cerebrovascular Disease Product Offerings
Table 32. Johnson & Johnson Cerebrovascular Disease Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Cerebrovascular Disease Product Offerings
Table 35. Amgen Cerebrovascular Disease Revenue (US$, Mn), (2017-2022)
Table 36. GlaxoSmithKline Corporate Summary
Table 37. GlaxoSmithKline Cerebrovascular Disease Product Offerings
Table 38. GlaxoSmithKline Cerebrovascular Disease Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi-Aventis Corporate Summary
Table 40. Sanofi-Aventis Cerebrovascular Disease Product Offerings
Table 41. Sanofi-Aventis Cerebrovascular Disease Revenue (US$, Mn), (2017-2022)
Table 42. Merck Corporate Summary
Table 43. Merck Cerebrovascular Disease Product Offerings
Table 44. Merck Cerebrovascular Disease Revenue (US$, Mn), (2017-2022)
Table 45. Sangamo BioSciences Corporate Summary
Table 46. Sangamo BioSciences Cerebrovascular Disease Product Offerings
Table 47. Sangamo BioSciences Cerebrovascular Disease Revenue (US$, Mn), (2017-2022)
Table 48. Aldagen Corporate Summary
Table 49. Aldagen Cerebrovascular Disease Product Offerings
Table 50. Aldagen Cerebrovascular Disease Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cerebrovascular Disease Segment by Type in 2021
Figure 2. Cerebrovascular Disease Segment by Application in 2021
Figure 3. Global Cerebrovascular Disease Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cerebrovascular Disease Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cerebrovascular Disease Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cerebrovascular Disease Revenue in 2021
Figure 8. By Type - Global Cerebrovascular Disease Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cerebrovascular Disease Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cerebrovascular Disease Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cerebrovascular Disease Revenue Market Share, 2017-2028
Figure 12. US Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cerebrovascular Disease Revenue Market Share, 2017-2028
Figure 16. Germany Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 17. France Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cerebrovascular Disease Revenue Market Share, 2017-2028
Figure 24. China Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 28. India Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cerebrovascular Disease Revenue Market Share, 2017-2028
Figure 30. Brazil Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cerebrovascular Disease Revenue Market Share, 2017-2028
Figure 33. Turkey Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cerebrovascular Disease Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GlaxoSmithKline Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi-Aventis Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sangamo BioSciences Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aldagen Cerebrovascular Disease Revenue Year Over Year Growth (US$, Mn) & (2017-2022)